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Breast cancer is cancer formed in the breast cells. Breast 
cancer is the most common malignancy in women, but it 
can occur less frequently in men. The incidence of breast 
cancer is increasing in the last decades of life. 75% occur 
in women over the age of 50, while 50% occur in women 
over the age of 65. The reason for breast cancer is 
unknown, but there is a risk factor for its occurrence. 
When it comes to malignancy in a particular case, breast 
cancer is known that there are certain risk groups of 
people who are at higher risk of this disease.  
 
Two different genes responsible for breast cancer have 
therefore been identified. In women who carry one of 
these two types of genes, there is a high risk of 
developing cancer. But if these women develop cancer, 
the prognosis and the possibility of death are the same as 
in women who do not carry the gene. These genes that 
are responsible for the development of breast cancer are 
called BRCA or Breast cancer gene. It stands for Breast 
Cancer BRCA1 and BRCA2, two different genes that 
have been found to play a huge role in the development 
of breast cancer. These genes play an important role in 
preventing breast cancer. They help repair DNA changes 
that can lead to cancer and uncontrolled tumor growth. 
They are also known for suppressing tumors or tumor 
suppressors. In some people, these suppression genes do 
not work properly. If the BRCA gene is mutated, then 
the DNA repairing is no longer effective and also in 
helping prevent breast cancer. People with gene 
mutations are more likely to develop breast cancer at a 
younger age. The differences between the two genes are 
that, BRCA1 - creates a tumor that does not grow under 
the action of estrogen hormones, while BRCA2 - creates 
a tumor that needs estrogen hormones to grow.  
 
Breast cancer is inherited or one in 20 cases. About 1 in 
1,000 people carries these genes responsible for cancer. 
Another risk factor is gender. The risk for breast cancer 
is higher in women than in men. Only 1% of breast 
cancer cases are associated with men. Age is also another 
risk factor. Older age is a higher risk factor, as around 
60% of breast cancers develop in women over 60 years 
of age. Women with a long menstrual history or early 
menarche as well as women who have never given birth 
or become pregnant after the age of 30 are at risk. In 
these women the risk of developing breast cancer is 2-3 
times higher than in women with a not so long menstrual 
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Breast cancer is the most common malignancy. Globally, it is most common cancer in women, affecting about 10% 
of  the female population at some stage in their lives. In addition to efforts to achieve early detection and effective 
treatment, about 20% of breast cancer patients die from this disease. We have witnessed a large number of infected 
women, but what is even more worrying is the fact that these are women from a younger population. Тhe purpose of 
this research is to get acquainted with this disease which is the most commonly diagnosed malignancy in women, 
defining the causes that lead to an increasing number of deaths from breast cancer and the role of the doctors in the 
prevention and early diagnosis of diseases. For this research was used analytical – descriptive method on the data 
taken from the Center for Public Health – Shtip (Shtip, Probishtip, Radovish) in the period from 2009 to 2018. 
According to the processed data, there is a growing number of deaths from breast cancer in this modern society. The 
disease endangers a woman's life which leads to disruption of her femininity, her physical health, her mental health 
and if not diagnosed in time leads to a fatal outcome. The need to conduct campaigns to raise awareness of women 
is inevitable, as well the approach of doctors in education, prevention and early diagnosis of this disease. 
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history and in women who gave birth before turning 30 
years old. Obesity after menopause - is a risk factor for 
breast cancer, which leads to the secretion of large 
amounts of estrogen hormones and the presence of these 
2 factors (obesity along with increased amounts of 
estrogen hormones) adversely affect breast tissue. 
Excessive alcohol consumption can increase the risk of 
breast cancer. Physical activity and regular exercise 
reduce the risk of breast cancer.  
 
According to the NCI (National Cancer Institute) the risk 
in a woman's lifetime of developing breast cancer is 
12.8%. The initial stages of cancer usually have no 
symptoms or completely unnoticeable signs, 
asymptomatic symptoms. By programming the process 
itself and the growth of the tumor, the leading symptoms 
will be noticed. Local symptoms of breast cancer are: 
palpable colorless lump (knot), although some may cause 
traction (but not all are carcinogenic), sensitive lump, 
redness of the skin, nipple changes such as nipple 
indentation, or wrinkled appearance, itching and burning 
or pus, nipple peeling should not be neglected, feeling of 
tightness on the skin of the chest, wart (erosion) of the 
nipple, chest asymmetry that is recent, change in nipple 
sensitivity, unusual nipple discharge that may be clear, 
serous, purulent, milky and bloody or of a different 
color; unusually persistent chest pain that is not related to 
a normal regular menstrual cycle, which persists after the 
cycle and occurs in one breast, visible flatness or 
depression of the breast, which may indicate a tumor that 
cannot be palpated.  
 
Тhere might also be present regional and systemic 
symptoms. Regional symptoms represent when there is a 
spread of cancer in regional lymph nodes. Most often it 
spreads in the armpit. Systemic symptoms occur if there 
are distant metastases in the body and depending on their 
location there may be symptoms such as: general 
weakness and malaise, nausea, vomiting, shortness of 
breath, suffocation, bone pain, swelling, jaundice, 
neurological outbursts and others symptoms.  
 
Breast cancer can be diagnosed by mammography, breast 
echotomography, tumor markers, magnetic resonance 
imaging (MRI), Immunohistochemistry and biops. After 
the diagnosis is made, the therapy begins. The therapy 




MATERIAL AND METHODS 
For this research, an analytical-descriptive method of 
work was applied in collecting and processing data with 
tabular and graphical presentation of results.  
 
The data was obtained from the Center for public health - 
municipality Stip, Macedonia for the number of 
outpatient polyclinic morbidity from breast cancer in the 
period from 2009 - 2018 in Stip, Probistip and Radovish. 
 
The aim of the research is to better understand the 
disease, to have a clear view on the statistics on the 
number of deaths from breast cancer, the age factor, 
morbidity, to define the causes that lead to an increased 
number of breast cancer patients, to explain that proper 
education, regular check-ups and examinations, timely 
detection of suspicious changes and early treatment are 
the main factors in reducing morbidity and mortality 
rates from breast cancer. 
 
RESULT AND DISCUSSION 
Table 1: Statistical data for outpatient polyclinic morbidity 2009-2018 on the territory of the Center for public 
















C50 women 4 9 34 88 91 65 24 
Men    1 1 2  
Year 
2010 
C50 women 0 7 31 81 79 55 30 
Men    2 3 3 2 
Year 
2011 
C50 women 0 5 26 93 83 73 27 
Men     2 1 2 
Year 
2012 
C50 women 0 6 26 100 90 119 30 
Men   1  7  1 
Year 
2013 
C50 women 0 8 29 113 110 155 34 
Men  1    1 2 
Year 
2014 
C50 women 0 13 32 98 151 149 38 
Men    1 1  2 
Year 
2015 
C50 women 0 1 45 109 124 155 35 
Men   1  3 1 4 
Year 
2016 
C50 women 0 4 38 136 141 157 45 
Men     1 3 4 
Year 
2017 
C50 women 0 7 23 74 141 129 42 
Men    2 2   
Year 
2018 
C50 women 0 7 42 101 127 118 30 
Men      1 3 
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Graphic 1: Malignant breast neoplasma in 2009 year in Stip, Probishtip and Radovish. 
 
 
Graphic 2: Malignant breast neoplasma in 2010 year in Stip, Probishtip I Radovish. 
 
 
Graphic 3: Malignant breast neoplasma in 2011 year in Stip, Probishtip and Radovish. 
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Graphic 4: Malignant breast neoplasma in 2012 year in Stip, Probishtip and Radovish. 
 
 
Graphic 5: Malignant breast neoplasma in 2013 year in Stip, Probishtip and Radovish. 
 
 
Graphic 6: Malignant breast neoplasma in 2014 year in Stip, Probishtip and Radovish. 
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Graphic 7: Malignant breast neoplasma in 2015 year in Stip, Probishtip and Radovish. 
 
 
Graphic 8: Malignant breast neoplasma in 2016 year in Stip, Probishtip and Radovish. 
 
 
Graphic 9: Malignant breast neoplasma in 2017 year in Stip, Probishtip and Radovish. 
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Graphic 10: Malignant breast neoplasma in 2018 year in Stip, Probishtip and Radovish. 
 
Table 2: Total number of polyclinic morbidity from 2009 to 2018 from breast cancer in the Eastern region, Stip, 
Probistip and Radovish. 
Women Men 
Year 2009 315 4 
Year 2010 283 10 
Year 2011 307 5 
Year 2012 371 9 
Year 2013 449 3 
Year 2014 481 4 
Year 2015 469 9 
Year 2016 521 8 
Year 2017 416 4 
Year 2018 425 4 
 
 
Graphic 11: Total number of polyclinic morbidity from 2009 to 2018 from breast cancer in the Eastern region. 
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Graphic 12: Statistics on the number of breast cancer morbidity prevalence by in the eastern region. 
 
Table 1 shows statistical data obtained from the Center 
for Public Health Stip - for the number of deaths from 
breast cancer for a period of ten years, ie from 2009 to 
2018. From the obtained results it can be noticed that the 
number of deceased from breast cancer increases with 
years, despite the fact that in advanced years the health is 
more developed. 
 
Table 1 shows the morbidity of breast cancer by age in 
the period from 2009 to 2018. The patients are divided 
into 7 different age groups. According to the obtained 
statistical data on the number of registered cases of 
breast cancer in the Eastern region, it is noted at what 
age the morbidity of breast cancer occurs the most. 
 
The prevalence in 2009 where the number is not very 
large, shows that mortality affects mostly both men and 
women aged from 55 to 64 years. In 2010 there is a 
decrease in the number of deceased patients from breast 
cancer, but mostly, the mortality for 2010 is noted 
between the ages 45-54. In 2011, a recurrent increase 
occurs in deaths in women. In 2012 is registered an 
increase in mortality between the age 65-74. In 2013, 
mortality was highest in patients aged 65-74. In 2014, 
female mortality most often occurred between the ages 
of 55-64. In 2015 and 2016, female highest mortality was 
between the ages of 65-74. While in 2017 and 2018 the 
mortality rate in women with breast cancer was more 
prevalent from 55-64 years of age. 
 
Table 2 shows statistics on the total number of morbidity 
in women and men with breast cancer. From the data 
presented it is clear that every year the number of women 
is much higher than men. 
 
The highest number of deaths from breast cancer in 
women are registered in 2016 and the lowest number in 
2010. 
 
The highest mortality rate among men was in 2010, 
while the lowest mortality rate was registered in 2013. 
 
Table 3 shows the statistical data on breast cancer 
mortality over 50 years of age according to cities in 
eastern Macedonia. The mortality is highest in Stip, then 
in Radovish, Delchevo, Probistip and St. Nikole with 
identical number, following Kocani and Berovo, and the 
lowest mortality from breast cancer in the Eastern region 
is in Vinica. 
 
Breast cancer is a modern disease that occurs in a large 
number of women of different ages, but it has been 
proven that this type of cancer, most often occurs in 
women over 50 years of age. The most important thing 
for this disease is to raise the awareness to the maximum 
level, so that it can be prevented or diagnosed earlier in 
order to provide better chances for treatment. 
 
Diagnosing and evaluating any malignancy is physically, 
mentally, and emotionally difficult for all patients. The 
most important thing is to understand the basis of the 
disease, to communicate in a way that the treatment 
would be realized, which would lead to the best results. 
Early diagnosis gives a chance for life. 
 
CONCLUSION 
According to the processed data, there is a growing 
number of deaths from breast cancer in this modern 
society. The disease endangers a woman's life which 
leads to disruption of her femininity, her physical health, 
her mental health and if not diagnosed in time leads to a 
fatal outcome. One of the main ways to solve this 
problem is the prevention or early detection, ie solving 
and eliminating the risk factors as well as the 
development of screening methods that lead to early 
detection or detection of the disease in stages in which 
the therapy is still highly effective. According to the 
processed data, it is noticed that breast cancer more often 
affects the older population, although some of the cases 
occur in younger people. Frequent early and regular 
check-ups, especially in high-risk patients, can reduce 
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